Skip to main content

Advertisement

SpringerLink
Log in

BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review

  • Review
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Breast cancer occurs rarely in male patient. BRCA1 gene mutation seems to be related to male breast cancer, but its role is not clearly defined. We have identified in a male patient affected by breast cancer the BRCA1 gene variant p.P142H. We performed a literature research using the keywords “male breast cancer”, “male breast cancer mutations” and “BRCA” and we reviewed the cases. We found ew other studies regarding BRCA1 variant p.P142H, about female subjects. At the moment, BRCA1 gene variant p.P142H is not certainly classified as neutral or deleterious. Genetic testing for BRCA1 and BRCA2 and PALB2 mutation gene has been performed on our patient. Segregation analysis for this p.P142H BRCA1 variant has been extended to the second generation of the family. Genetic tests revealed a clear inheritance regarding the BRCA1 gene p. P142H variant. Of the eight patients with this specific genetic mutation, four presented breast cancer (bilateral in one case), two female and two male. None of the subjects in the family without the BRCA1 gene variant p. P142H presented breast cancer or other BRCA1 gene mutation-related cancers. Our analysis suggests that the BRCA1 gene variant p.P142H mutation is related with male breast cancer. Starting from these data, it can be inferred that more studies on MBC and its relation with the BRCA1 gene mutation P142H variant must be undertaken to improve prognostic and therapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sousa B, Moser E, Cardoso F (2013) An update on male breast cancer and future directions for research and treatment. Eur J Pharmacol 717(1–3):71–83

    Article  CAS  PubMed  Google Scholar 

  2. Wasielewski M, den Bakker MA, van den Ouweland A et al (2009) CHEK2 1100delC and male breast cancer in the Netherlands. Breast Cancer Res Treat 116(2):397–400

    Article  CAS  PubMed  Google Scholar 

  3. Ohayon T, Gal I, Baruch RG et al (2004) CHEK2 1100delC and male breast cancer risk in Israel. Int J Cancer 108(3):479–480

    Article  CAS  PubMed  Google Scholar 

  4. Blanco A, de la Hoya M, Balmana J et al (2012) Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer. Breast Cancer Res Treat 132(1):307–315

    Article  PubMed  Google Scholar 

  5. Young IE, Kurian KM, Annik C et al (1999) A polymorphism in the CYP17 gene is associate with male breast cancer. Br J Cancer 81(1):141–143

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Katri P, Hannele E, Jenni N, Szilvia S, Robert W (2008) Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families. BMC Cancer 8:146

    Article  Google Scholar 

  7. Blay P, Santamaría I, Pitiot AS, Luque M, Alvarado MG, Lastra A et al (2013) Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain). BMC Cancer 13:243

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Frank TS, Deffendaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490

    Article  CAS  PubMed  Google Scholar 

  9. Hyo JK, Young BH, Yong WY, Chi-Heum C, Antai W, Insoo B (2013) The correlations between BRCA1 defect and environmental factors in the risk of breast cancer. J Toxicol Sci 38(3):355–361

    Article  Google Scholar 

  10. Bielinska B, Gaj P, Kluska A, Nowakowska D, Balabas A et al (2013) Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer. Fam Cancer 12(4):691–698

    Article  CAS  PubMed  Google Scholar 

  11. Chenevix-Trench G, Healey S, Lakhani S et al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66(4):2019–2027

    Article  CAS  PubMed  Google Scholar 

  12. Easton DF, Deffenbaugh AM, Pruss D et al (2007) A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81(5):873–883

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Judkins T, Hendrickson BC, Deffenbaugh AM (2005) Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. Cancer Res 65(21):10096–10103

    Article  CAS  PubMed  Google Scholar 

  14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    Article  PubMed  Google Scholar 

  15. Hodgson NC, Button JH, Franceschi D et al (2004) Male breast cancer: is the incidence increasing? Ann Surg Oncol 11(8):751–755

    Article  PubMed  Google Scholar 

  16. Speirs V, Shaaban AM (2009) The rising incidence of male breast cancer. Breast Cancer Res Treat 115(2):429–430

    Article  PubMed  Google Scholar 

  17. White J, Kearins O, Dodwell D et al (2011) Male breast carcinoma: increased awareness needed. Breast Cancer Res 13(5):219

    Article  PubMed Central  PubMed  Google Scholar 

  18. Ruddy KJ, Winer EP (2013) Male Breast Cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 24(6):1434–1443

    Article  CAS  PubMed  Google Scholar 

  19. Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595–604

    Article  PubMed  Google Scholar 

  20. Falchetti M, Lupi R, Rizzolo P et al (2008) BRCA1/BRCA2 rearragements and CHEK 2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat 110(1):161–167

    Article  CAS  PubMed  Google Scholar 

  21. Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M et al (2012) Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy. Breast Cancer Res Treat 134(1):411–418

    Article  CAS  PubMed  Google Scholar 

  22. Deb S, Do H, Byrne D, Jene N, kConFab Investigators, Dobrovic A, Fox SB (2013) PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer. Breast Cancer Res 15:69

    Article  Google Scholar 

  23. Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811–1814

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Kwiatkowska E, Teresiak M, Filas V et al (2003) BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients. Clin Cancer Res 9:4452–4459

    CAS  PubMed  Google Scholar 

  25. Young-Ho L, Ching-Ying K, Jeremy MS, David KA et al (2013) HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response. Nucleic Acids Res 41(11):5784–5798

    Article  Google Scholar 

  26. Li M, Yu X (2013) Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell 23(5):693–704

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. De Luca P, Moiola CP, Zalazar F, Gardner K, Vazquez ES (2013) BRCA1 and p53 regulate critical prostate cancer pathways. Prostate Cancer Prostatic Dis 16(3):233–238

    Article  PubMed  Google Scholar 

  28. Levy-Lahad E, Friedman E (2007) Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 96(1):11–15

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Han SA, Park SK, Ahn SH et al (2011) The Korean Hereditary Breast Cancer (KOHBRA) Study: protocols and Interim Report. Clinical Oncology 23(7):434–441

    Article  PubMed  Google Scholar 

  30. Fiala L, Coufal O, Fait V, Foretová L (2010) Male breast cancer–our experience. Rozhl Chir 89(10):612–618

    CAS  PubMed  Google Scholar 

  31. Varesco L, Viassolo V, Viel A et al (2013) Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: a retrospective study in a sample of Italian cancer genetics clinics. The Breast 22(6):1130–1135

    Article  CAS  PubMed  Google Scholar 

  32. Kast K, Schmutzler RK, Rhiem K et al (2014) Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer. Int J Cancer. doi:10.1002/ijc.28875

    Google Scholar 

  33. Millot GA, Carvalho MA, Caputo SM et al (2012) A guide for functional analysis of BRCA1 variants of uncertain significance. Hum Mutat 33(11):1526–1537

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Wei L, Lan L, Hong Z et al (2008) Rapid recruitment of BRCA1 to DNA double-strand breaks is dependent on its association with Ku80. Mol Cell Biol 24:7380–7393

    Article  Google Scholar 

  35. Towler WI, Zhang J, Ransburgh DJ et al (2013) Analysis of BRCA1 variants in double-strand break repair by homologous recombination and single-strand annealing. Hum Mutat 34(3):439–445

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Surgical, Medical, Pathological, Molecular and Critic Area, University of Pisa, Via Paradisa 2, 56124, Pisa, Italy

    Claudio Spinelli, Silvia Strambi, Lorenzo Piccini & Leonardo Rossi

  2. Science Foundation of Pisa, Pisa, Italy

    Paolo Aretini

  3. Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, Pisa, Italy

    Adelaide Caligo

Authors
  1. Claudio Spinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Silvia Strambi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorenzo Piccini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leonardo Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Aretini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Adelaide Caligo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio Spinelli.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spinelli, C., Strambi, S., Piccini, L. et al. BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review. Familial Cancer 14, 515–519 (2015). https://doi.org/10.1007/s10689-015-9819-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-015-9819-7

Keywords

Search

Navigation